ReviewFrontiers in pharmacology2022

ACSL4 as a Potential Target and Biomarker for Anticancer: From Molecular Mechanisms to Clinical Therapeutics.

Jun Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.